General Information
Revision date
2019-07-18
Product name
Candesartan Impurity Standard
1.2.1 Relevant identified uses
Reference material for laboratory use only
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
+44 (0)20 3080 6561 (Monday - Friday 8am - 5pm
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D, H362, H373, H400, H410
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
CLP CLASSIFICATION
GHS08 health hazard Repr. 1A H360D-H362 May damage the unborn child. May cause harm to breast-fed children. STOT RE 2 H373 May cause damage to organs through prolonged or repeated exposure. GHS09 environment Aquatic Acute 1 H400 Very toxic to aquatic life. Aquatic Chronic 1 H410 Very toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The product is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS08 GHS09
Signal word
Danger
Hazardous Ingredients
Candesartan Cilexetil Candesartan cilexetil impurity D EP
Hazard statements
H360D-H362 May damage the unborn child. May cause harm to breast-fed children. H373 May cause damage to organs through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P260 Do not breathe dusts or mists. P263 Avoid contact during pregnancy/while nursing. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
Restricted to professional users.
PBT Substances
Not applicable
vPvB Substances
Not applicable
